BioPharma Bitez: Verona, Aptinyx, and more!

Happy Friday everybody, welcome to this week’s edition of “BioPharma Bitez.” Top news in the industry as well as one story outside of it. Now, with a new, shinier, backdrop! So, to kick it off this week, Verona suffered a “phase two failure” for a COPD bronchodilator product. It would… Read more

BioPharma Bitez: GSK, Vanda, Abbvie, and more!

Happy Friday everybody! Welcome to this week’s edition of “BioPharma Bitez”, the top news of the industry as well as one outside of it. So, to kick it off this week, the obvious story is GSK buying Tesaro for 5 billion dollars. This will actually expand GSK’s commercial oncology portfolio. We… Read more

The Value of Trade shows

 I wanted to continue the discussion with effective marketing strategies. All of these tips should be used in tandem. So, we’ve got “MPC marketing” finding those impact players, critically important. Building your brand through social media, doing a post, just getting active in those areas. Do more today than… Read more

BioPharma Bitez: AstraZeneca, Biogen, and more!

Happy Friday everybody, welcome to this week’s episode of “BioPharma Bitez,” the top news of the industry, as well as one interesting story outside of it. So, to kick it off, Bain Capital announced this week they’re going to back a start-up called “Cerevel” which is a neuroscience-based pipeline that… Read more

What Candidates Tell Recruiters

Hi, my name is Jessica Penney and I am an executive recruiter here at Govig and Associates. I specialize in the building products industry, especially working closely with window and door companies, nationwide. Today, I wanted to talk to you about what candidates tell recruiters, that they do not typically… Read more

How to Leverage Social Media

Hi, my name is Neil Hefta, vice president with Govig Healthcare Group. I have been an executive recruiter since 1998 actually worked in the nursing home industry as an administrator. And today I wanted to share a fun video from a recruiters perspective of 20 years on the value of LinkedIn.… Read more